A Basic Biological Question Leads to the First FDA-Approved Treatment for Rare Blood Disorder

December 13, 2023


Read time:

5-15 mins
Ginsburg Blood Clot

According to geneticist and professor David Ginsberg, M.D., the questions that drive scientists’ day-to-day work are more straightforward than you might think. By indulging his curiosity over the source of unique blood clotting patterns in patients with TTP, Ginsberg’s research led to the approval of life-saving treatments for rare, potentially lethal blood disorders.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.